XML 30 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of Cash Flows - ARS ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities      
Loss for the year $ (17,468) $ (41,577) $ (52,017)
Adjustments to reconcile net (loss) profit to net cash flows from operating activities:      
Depreciation of property, plant and equipment 18,193 17,728 19,113
Depreciation of right-of-use assets 1,033 892 932
Loss on disposals of property, plant and equipment 348 485 442
Net accrued interest 87,563 52,319 27,156
Income from customer surcharges (3,031) (3,771) (4,556)
Exchange difference (1,478) 3,120 8,684
Income tax 14,834 30,455 (10,472)
Allowance for the impairment of trade and other receivables, net of recovery 2,199 3,822 12,293
Adjustment to present value of receivables 338 292 380
Provision for contingencies, net of recovery 4,405 4,580 2,006
Changes in fair value of financial assets (2,825) (7,728) (2,907)
Accrual of benefit plans 1,202 1,471 1,402
Recovery of provision for credit RDSA (Note 38) (1,130)
Net gain from the cancelattion of Corporate Notes 363 (6) (1,219)
Loss on debt restructuring 449
Impairment of property, plant and equipment 51,129
Income from non-reimbursable customer contributions (62) (91) (78)
Other financial results 4,583 2,061 606
Gain from interest in joint ventures 6 (4)
Agreement on the Regularization of Obligations (18,136)
Recovery of allowance for the impairment of trade receivables - Agreement on the Regularization of Obligations (2,650)
Monetary gain (RECPAM) (99,617) (46,440) (28,700)
Changes in operating assets and liabilities:      
Increase in trade receivables (6,929) (5,236) (11,236)
Increase in other receivables (11,969) (1,574) (1,029)
(Increase) Decrease in inventories (2,319) (1,650) 97
Increase in financial assets at amortized cost (931)
Increase in deferred revenue 2,052 526 3,701
Increase in trade payables 61,843 35,524 39,884
Increase in salaries and social security payable 5,197 1,708 5,030
Decrease in benefit plans (267) (138) (41)
Decrease in tax liabilities (467) (3,830) (267)
(Decrease) Increase in other payables (1,331) 364 (158)
Derivative financial instruments payments (853)
Decrease in provisions (537) (586) (343)
Payment of income tax payable (96) (7,112)
Net cash flows generated by operating activities 35,426 41,586 50,936
Cash flows from investing activities      
Payment of property, plants and equipments (31,726) (28,686) (28,942)
Purchase net of Mutual funds and negotiable instruments (5,477) (21,084) (7,786)
Derivative financial instruments payments (157)
Mutuum charges granted to third parties 10 103
Collection of receivables from sale of subsidiaries 29
Net cash flows used in investing activities (37,360) (49,760) (36,596)
Cash flows from financing activities      
Proceeds from borrowings 4,420
Payment of borrowings (6,078) (2,204)
Payment of lease liability (1,171) (1,025) (2,016)
Payment of interests from borrowings (896) (1,743) (2,698)
Payment of Corporate Notes issuance expenses (565)
Cancelattion of Corporate Notes (472) (33) (11,164)
Net cash flows used in financing activities (4,762) (2,801) (18,082)
Decrease in cash and cash equivalents (6,696) (10,975) (3,742)
Cash and cash equivalents at the beginning of year 6,179 12,821 12,802
Financial results in cash and cash equivalents 2,173 4,341 2,700
Result from exposure to inflation (26) (8) 1,061
Decrease in cash and cash equivalents (6,696) (10,975) (3,742)
Cash and cash equivalents at the end of the year 1,630 6,179 12,821
Supplemental cash flows information      
Adquisition of advances to suppliers, property, plant and equipment through increased trade payables (2,174) (2,967) (3,596)
Adquisition of advances to suppliers, right-of-use assets through increased trade payables $ (912) $ (1,050) $ (723)